Xspray Pharma Future Growth
Future criteria checks 5/6
Xspray Pharma is forecast to grow earnings and revenue by 134.8% and 134.5% per annum respectively while EPS is expected to grow by 126.6% per annum.
Key information
134.8%
Earnings growth rate
126.6%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 134.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,618 | 818 | N/A | N/A | 2 |
| 12/31/2025 | 498 | -60 | -154 | -60 | 2 |
| 12/31/2024 | 5 | -216 | -283 | -198 | 1 |
| 9/30/2024 | N/A | -258 | -232 | -193 | N/A |
| 6/30/2024 | N/A | -215 | -259 | -221 | N/A |
| 3/31/2024 | N/A | -213 | -257 | -213 | N/A |
| 12/31/2023 | N/A | -180 | -256 | -203 | N/A |
| 9/30/2023 | N/A | -180 | -268 | -206 | N/A |
| 6/30/2023 | N/A | -170 | -242 | -160 | N/A |
| 3/31/2023 | N/A | -148 | -223 | -128 | N/A |
| 12/31/2022 | N/A | -132 | -238 | -110 | N/A |
| 9/30/2022 | N/A | -128 | -216 | -85 | N/A |
| 6/30/2022 | N/A | -114 | -198 | -79 | N/A |
| 3/31/2022 | N/A | -102 | -185 | -67 | N/A |
| 12/31/2021 | N/A | -97 | -148 | -52 | N/A |
| 9/30/2021 | N/A | -60 | -146 | -53 | N/A |
| 6/30/2021 | N/A | -57 | -145 | -49 | N/A |
| 3/31/2021 | N/A | -56 | -141 | -46 | N/A |
| 12/31/2020 | N/A | -52 | -141 | -48 | N/A |
| 9/30/2020 | N/A | -56 | -141 | -48 | N/A |
| 6/30/2020 | N/A | -55 | -140 | -44 | N/A |
| 3/31/2020 | N/A | -49 | -135 | -35 | N/A |
| 12/31/2019 | N/A | -46 | -126 | -34 | N/A |
| 9/30/2019 | -22 | -41 | -115 | -29 | N/A |
| 6/30/2019 | -14 | -34 | -97 | -24 | N/A |
| 3/31/2019 | -6 | -30 | -91 | -27 | N/A |
| 12/31/2018 | 0 | -23 | -65 | -18 | N/A |
| 9/30/2018 | 31 | -17 | -62 | -25 | N/A |
| 6/30/2018 | 28 | -16 | N/A | -12 | N/A |
| 3/31/2018 | 29 | -8 | N/A | -7 | N/A |
| 12/31/2017 | 0 | -14 | N/A | -12 | N/A |
| 9/30/2017 | 35 | 1 | N/A | 12 | N/A |
| 6/30/2017 | 30 | -3 | N/A | -2 | N/A |
| 3/31/2017 | 21 | -7 | N/A | -6 | N/A |
| 12/31/2016 | 21 | -4 | N/A | -2 | N/A |
| 12/31/2015 | 5 | -12 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6XP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 6XP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 6XP is expected to become profitable in the next 3 years.
Revenue vs Market: 6XP's revenue (134.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 6XP's revenue (134.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6XP's Return on Equity is forecast to be high in 3 years time